When compared individually to oxytocin, misoprostol, and oxytocin+misoprostol combination, the use of heat-stable carbetocin for PPH prevention resulted in fewer cases of PPH by 28.4%, 33.8%, and 20.0%, respectively. The gene discussed is OXT; the disease is pulmonary arterial hypertension.